University of Southern California Atherosclerosis Research Unit
Los Angeles, California, United States
About University of Southern California Atherosclerosis Research Unit
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at University of Southern California Atherosclerosis Research Unit
During the past decade, University of Southern California Atherosclerosis Research Unit conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Southern California Atherosclerosis Research Unit"
#1 collaborator was "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at University of Southern California Atherosclerosis Research Unit
According to Clinical.Site data, the most researched conditions in "University of Southern California Atherosclerosis Research Unit" are
"Atherosclerosis" (1 trials), "Cognitive Decline" (1 trials), "Prevention of Cognitive Decline" (1 trials) and "Prevention of Subclinical Atherosclerosis Progression" (1 trials). Many other conditions were trialed in "University of Southern California Atherosclerosis Research Unit" in a lesser frequency.
Clinical Trials Intervention Types at University of Southern California Atherosclerosis Research Unit
Most popular intervention types in "University of Southern California Atherosclerosis Research Unit" are "Combination Product" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Nattokinase" (1 trials) and "Oral bazedoxifene 20 mg / conjugated estrogens 0.45 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Southern California Atherosclerosis Research Unit
The vast majority of trials in "University of Southern California Atherosclerosis Research Unit" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at University of Southern California Atherosclerosis Research Unit
Currently, there are NaN active trials in "University of Southern California Atherosclerosis Research Unit".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in University of Southern California Atherosclerosis Research Unit,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of Southern California Atherosclerosis Research Unit, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".